|1.||Guan, Zhong-Zhen: 5 articles (12/2007 - 04/2003)|
|2.||Zhu, Jun: 4 articles (03/2015 - 12/2005)|
|3.||Tsurumi, Hisashi: 4 articles (01/2014 - 11/2002)|
|4.||Moriwaki, Hisataka: 4 articles (01/2014 - 11/2002)|
|5.||Jiang, Wen-Qi: 4 articles (02/2009 - 08/2003)|
|6.||He, You-Jian: 4 articles (12/2007 - 04/2003)|
|7.||Xia, Yi: 3 articles (10/2015 - 12/2007)|
|8.||Hong, Xiaonan: 3 articles (03/2015 - 06/2012)|
|9.||Takami, Tsuyoshi: 3 articles (01/2014 - 05/2012)|
|10.||Goto, Naoe: 3 articles (01/2014 - 05/2012)|
|1.||Non-Hodgkin Lymphoma (Lymphosarcoma)
10/01/2012 - "The patient was put on CHOP regimen targeted for high grade lymphomas, and had complete remission. "
08/01/2003 - "For newly diagnosed non-Hodgkin's lymphoma (NHL), CHOP regimen shows good response, but quite a few patients belong to intrinsic drug resistance, or relapse after complete remission (CR). "
10/01/1995 - "Until now, literature data support the fact that the CHOP regimen represents the standard first line treatment for patients with advanced intermediate-grade non-Hodgkin's lymphoma. "
03/01/2000 - "Since the study by SWOG in 1993, CHOP regimen has been the standard therapy for patients with advanced stage intermediate-grade or high-grade non-Hodgkin's lymphoma. "
04/01/2011 - "Thirty patients with newly diagnosed non-Hodgkin lymphoma (NHL) treated with the first course of an R-CHOP regimen were enrolled randomly. "
10/15/2013 - "The study indicated that cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen is relatively high and ECG monitoring may be the most effective in cardiological risk assessment. "
02/01/2009 - "The patient was treated with 6 courses of CHOP regimen, resulting in complete remission of lymphoma. "
08/01/2011 - "In conclusion, we can point out that intensification could enhance the efficacy of the R-CHOP regimen and improve overall survival in patients with non germinal lymphoma."
10/01/1998 - "The M-CHOP regimen seems to be a promising treatment for primary malignant lymphoma in the central nervous system."
12/01/1996 - "The efficacy of dose intensification of CPA in CHOP regimen for patients with aggressive lymphoma is being investigated in some clinical trials. "
|3.||Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
06/01/2010 - "The R-CHOP regimen has been found to improve the outcome of diffuse large B-cell lymphoma (DLBCL). "
08/01/1984 - "Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen."
10/01/2015 - "Our results indicate that survivin is an independent prognostic factor for poor outcome in patients with activated B cell-like disease treated with the R-CHOP regimen, and patients with survivin-positive activated B cell-like diffuse large B-cell lymphoma seem to benefit less from this treatment and may require additional novel agents. "
01/01/2015 - "Here we describe a case of PSL detected by ¹⁸F-FDG-PET/CT which was histopathologically proven to be diffuse large B-cell lymphoma (DLBCL) treated with CHOP regimen. "
12/01/2014 - "ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen."
|4.||Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/01/2013 - "Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas."
11/01/2004 - "[Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen]."
11/01/2004 - "This study was designed to analyse the clinical characteristics and to evaluate the effectiveness and toxicity of standard CHOP regimen in the treatment of peripheral T-cell lymphomas-unspecified (PTCL-U) according to the Revised European- American Lymphoma (REAL) classification. "
01/01/2006 - "We investigated the efficacy of a dose-intensified double-CHOP regimen followed by high-dose chemotherapy with or without peripheral blood stem cell transplantation (PBSCT) in 11 patients with four types of peripheral T-cell lymphoma (PTCL). "
01/01/2006 - "Treatment of high-risk peripheral T-cell lymphomas other than anaplastic large-cell lymphoma with a dose-intensified CHOP regimen followed by high-dose chemotherapy. "
05/01/1991 - "She was treated with CHOP regimen and irradiation, resulting of decreased tumor size and population of CD4+/CD8+."
11/01/2004 - "106 patients with PTCL-U were treated by standard CHOP regimen with or without involved field radiotherapy from January 1997 to December 2003 in Cancer Center, Sun Yat-sen University, The clinical characteristics, response and long-term survival rates were analysed, retrospectively. "
02/01/1998 - "The tumor cells were detected in her peripheral blood despite four courses of combination chemotherapy using CHOP regimen. "
09/01/1996 - "The patient received three cycles (every 21 days) of CHOP regimen for Non Hodgkin's lymphoma and to maintain a static state of oesophageal cancer. "
01/01/2009 - "Immunosuppression reduction, chemotherapy with CHOP regimen and local radiotherapy induced complete remission of the tumor."
|7.||Etoposide (VP 16)
|8.||Granulocyte Colony-Stimulating Factor (G-CSF)
|9.||Idarubicin (4 Demethoxydaunorubicin)
|1.||Drug Therapy (Chemotherapy)
|3.||Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
|5.||Stem Cell Transplantation